Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy.

@article{Lee2009ProspectiveTI,
  title={Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy.},
  author={N. Y. Louis Lee and Sadek A. Nehmeh and Heiko Sch{\"o}der and Matthew S Fury and Kelvin C. F. Chan and C. Clifton Ling and John L. Humm},
  journal={International journal of radiation oncology, biology, physics},
  year={2009},
  volume={75 1},
  pages={101-8}
}
PURPOSE To report the results from a prospective study of a series of locoregionally advanced head-and-neck cancer patients treated with platinum-based chemotherapy and intensity-modulated radiotherapy and to discuss the findings of their pre-/mid-treatment [(18)F]-misonidazole ((18)F-FMISO) positron emission tomography (PET) scans. METHODS AND MATERIALS A total of 28 patients agreed to participate in this study. Of these 28 patients, 20 (90% with an oropharyngeal primary cancer) were able to… CONTINUE READING